• The management of Cohance Lifesciences Limited will be attending the Kotak Midcap Conference 2026 as part of investor relations activities.
  • The event is scheduled for 27 November 2026 in Mumbai.
  • The format includes both Group and One-on-One meetings with analysts and institutional investors.
  • The stated purpose is participation in an institutional investor conference for investor outreach and engagement.
  • The company explicitly states: "No unpublished price-sensitive information will be shared during this interaction."
  • The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • No specific management participants or their designations were disclosed in this filing.
  • The document does not mention any presentation, earnings deck, transcript, or recording being made available.

Additional Notes Section

  • The document includes a note that the schedule is subject to change due to exigencies on the part of analysts, institutional investors, or the company.
  • No financial data, guidance references, or presentation summaries were included in this announcement.
  • The letter was digitally signed by Sisir K. Mishra, Company Secretary & Compliance Officer, on November 20, 2026.